Peptide stacks on TikTok: what the 'current stack' trend gets right and wrong

A recent TikTok by Amy’s Pep Journey asks viewers, “What’s your current stack!?” and directs them to a branded peptide site with a discount code. The video also tags other peptide influencers, encouraging a community-wide sharing of personal protocols. The underlying claim is that combining multiple peptides—often in “stacks”—is a normal, evidence-based practice that can be personalized for anti-aging, women’s health, and biohacking goals.

What the clip is claiming

The clip implies that peptide stacking is a mainstream, research-supported approach. By asking for “current stacks,” it normalizes the idea that using several peptides at once is not only safe but also more effective than single-peptide use. The tags and discount code further suggest that these stacks are best sourced from a particular vendor, adding a commercial layer to the health advice.

What the research neighborhood actually covers

Peptide research is real and growing. For example, GHK-Cu has been studied for wound healing and skin regeneration, with multiple peer-reviewed papers on its role in collagen production and antioxidant activity. BPC-157 has been investigated in animal models for gastrointestinal and tendon healing. NAD+ precursors are studied for cellular energy and aging. However, these studies are almost always conducted on individual peptides, not on combinations. The concept of “stacking” is largely anecdotal, derived from user reports and practitioner forums, not from controlled clinical trials.

Limits, missing context, and what a 15-second clip cannot show

A short video cannot convey the complexity of peptide interactions, dosing schedules, or potential side effects. It also omits the fact that most peptides are not FDA-approved for the uses discussed; they are sold for research purposes only. The clip also fails to mention that “stacks” often include compounds with overlapping or opposing mechanisms, and no research has established safe or effective ratios. Furthermore, the influencer’s financial incentive—via discount codes—creates a conflict of interest that is not disclosed in the video.

How this maps to named research compounds

If we look at the catalog of research peptides, several are commonly mentioned in stacking discussions. For example, GHK-Cu is often paired with BPC-157 for skin and tissue repair, but no published study validates this combination. Similarly, CJC-1295 without DAC and Ipamorelin are frequently combined as a growth hormone secretagogue stack, yet clinical evidence for their synergy is lacking. NAD+ is sometimes added to “anti-aging” stacks, but its interaction with other peptides is unexplored. The “Glow” blend, which typically contains GHK-Cu, BPC-157, and TB-500, is a commercial product, but its individual components have separate research profiles—not a combined one.

Research-use caveat

All peptides listed in a research catalog are intended for laboratory and investigational use only, not for human consumption. The FDA has not approved these compounds for any medical indication. Any discussion of “stacks” is speculative and should be confined to controlled research settings. Individuals should not attempt to replicate protocols seen on social media.

Open the full video fact-check page (transcript, takeaways, embedded clip).